Gamal E Shiha
Overview
Explore the profile of Gamal E Shiha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A, et al.
Hepatol Int
. 2025 Feb;
19(1):1-69.
PMID: 39961976
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the...
2.
Kumar A, Arora A, Choudhury A, Arora V, Rela M, Jothimani D, et al.
Am J Gastroenterol
. 2024 Jul;
PMID: 39016385
Introduction: The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) and its complication, MAFLD-related acute-on-chronic liver failure (MAFLD-ACLF), is rising. Yet, factors determining patient outcomes in MAFLD-ACLF remain understudied. Methods:...
3.
Toson E, Shiha G, El-Sharkawy A, El-Mezayen H
Eur J Gastroenterol Hepatol
. 2019 Nov;
32(8):990-997.
PMID: 31743229
Background/aim: Liver fibrosis assessment and evaluation of disease severity in hepatitis C virus (HCV) patients provides useful information for therapeutic decisions. Chronic HCV infection is associated with increased levels of...
4.
Shiha G, El-Etreby S, Bahgat M, Hamed M, El Sherbini M, Ghoneem E, et al.
Ann Hepatol
. 2018 Aug;
17(5):795-801.
PMID: 30145567
Introduction And Aim: Transient elastography is gaining popularity as a non-invasive method for predicting liver fibrosis, but inter observer agreement and factors influencing reproducibility have not been adequately assessed. Material...
5.
Toson E, Shiha G, Abdelgaleel A
Ann Hepatol
. 2017 Oct;
16(6):862-873.
PMID: 29055924
Results: Samples were collected from 220 patients (F0-F4): an estimated group (n = 120) and a validated group (n = 100). HA and VEGF levels, HCV RNA, liver function tests,...
6.
Toson E, Shiha G, El-Mezayen H, Samir W, El-Khininy M
Eur J Gastroenterol Hepatol
. 2016 Dec;
29(2):199-207.
PMID: 27930387
Background/aim: The assessment of liver fibrosis provides useful information not only for diagnosis but also for therapeutic decisions. This study aimed to develop and evaluate a predictive score named the...
7.
Toson E, Shiha G, El-Mezayen H, El-Sharkawy A
Eur J Gastroenterol Hepatol
. 2016 May;
28(8):931-9.
PMID: 27159125
Background/aims: Evaluation of liver fibrosis in patients infected with hepatitis C virus is highly useful for the diagnosis of the disease as well as therapeutic decision. Our aim was to...
8.
Attallah A, El-Far M, Zahran F, Shiha G, Farid K, Omran M, et al.
J Immunoassay Immunochem
. 2016 Apr;
37(6):597-610.
PMID: 27093468
The relation between interferon-gamma (IFN-γ) levels and the severity of liver diseases through fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) has not been fully clarified. Thus, we aimed to characterize IFN-γ...
9.
Attallah A, El-Far M, Abdel Malak C, Omran M, Shiha G, Farid K, et al.
Tumour Biol
. 2015 May;
36(10):7667-74.
PMID: 25929809
Currently, the search for suitable hepatocellular carcinoma (HCC) biomarkers is very intensive. Besides, efficacy and cost/effectiveness of screening and surveillance of cirrhotics for the diagnosis of HCC is still debated....
10.
Shiha G, Abu-Elsaad N, Zalata K, Ibrahim T
Clin Exp Pharmacol Physiol
. 2014 Aug;
41(10):788-97.
PMID: 25115651
The tyrosine kinase inhibitors imatinib and nilotinib have been suggested to have promising antifibrotic activity in experimental models of liver fibrosis. The aim of the present study was to investigate...